Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

In vitro selection of the 3'-untranslated regions of the human liver mRNA that bind to the HCV nonstructural protein 5B.

Yuhashi K, Ohnishi S, Kodama T, Koike K, Kanamori H.

Virology. 2014 Feb;450-451:13-23. doi: 10.1016/j.virol.2013.11.036. Epub 2013 Dec 18.

2.
3.
4.

Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A.

Rosnoblet C, Fritzinger B, Legrand D, Launay H, Wieruszeski JM, Lippens G, Hanoulle X.

J Biol Chem. 2012 Dec 28;287(53):44249-60. doi: 10.1074/jbc.M112.392209. Epub 2012 Nov 14.

6.

Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase.

Huang JT, Tseng CP, Liao MH, Lu SC, Yeh WZ, Sakamoto N, Chen CM, Cheng JC.

J Virol. 2013 May;87(9):4994-5004. doi: 10.1128/JVI.02526-12. Epub 2013 Feb 20.

7.
8.

A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase.

Hong Z, Cameron CE, Walker MP, Castro C, Yao N, Lau JY, Zhong W.

Virology. 2001 Jun 20;285(1):6-11.

9.

Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.

Kumar D, Chaudhury I, Kar P, Das RH.

J Gastroenterol Hepatol. 2009 May;24(5):872-8. doi: 10.1111/j.1440-1746.2008.05717.x. Epub 2009 Feb 9.

PMID:
19220662
10.

Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.

Nikonov A, Juronen E, Ustav M.

J Biol Chem. 2008 Aug 29;283(35):24089-102. doi: 10.1074/jbc.M803422200. Epub 2008 Jun 23.

11.

Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.

Kang SM, Choi SH, Park CY, Kim MH, Kim TK, Park JM, Koh MS, Kang HJ, Hwang SB.

J Viral Hepat. 2008 Apr;15(4):305-13. doi: 10.1111/j.1365-2893.2007.00945.x.

PMID:
18307593
13.

Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase.

Ingravallo P, Lahser F, Xia E, Sodowich B, Lai VC, Hong Z, Zhong W.

Virus Res. 2001 Jun;75(2):179-87.

PMID:
11325472
14.

Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli.

Al RH, Xie Y, Wang Y, Hagedorn CH.

Virus Res. 1998 Feb;53(2):141-9.

PMID:
9620206
15.

HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication.

Shwetha S, Kumar A, Mullick R, Vasudevan D, Mukherjee N, Das S.

J Virol. 2015 Nov;89(22):11356-71. doi: 10.1128/JVI.01714-15. Epub 2015 Sep 2.

16.

De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.

Zhong W, Uss AS, Ferrari E, Lau JY, Hong Z.

J Virol. 2000 Feb;74(4):2017-22.

17.

Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture.

Cheney IW, Naim S, Lai VC, Dempsey S, Bellows D, Walker MP, Shim JH, Horscroft N, Hong Z, Zhong W.

Virology. 2002 Jun 5;297(2):298-306.

18.

De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus.

Luo G, Hamatake RK, Mathis DM, Racela J, Rigat KL, Lemm J, Colonno RJ.

J Virol. 2000 Jan;74(2):851-63.

20.

Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.

McKercher G, Beaulieu PL, Lamarre D, LaPlante S, Lefebvre S, Pellerin C, Thauvette L, Kukolj G.

Nucleic Acids Res. 2004 Jan 22;32(2):422-31. Print 2004.

Supplemental Content

Support Center